If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
10 mM and 20 mM ferric chloride), 90 µL of the extract and 0.27 mL of distilled water. After homogenization, the sample was incubated at 37 °C for 30 min and reading was performed at 595 nm. The ABTS ...
A new environmental report finds that rising salt levels in New York City’s water supply could make some of it undrinkable by ...
A study in Engineering reveals a new adsorbent made by combining cationic surfactants with montmorillonite. This adsorbent ...
PROCEPT BioRobotics announced positive WATER III trial results for Aquablation therapy in large prostates, showing effective outcomes and reduced complications. PROCEPT BioRobotics Corporation ...
SAN JOSE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
WATER III is an international, prospective, multicenter study comparing Aquablation therapy to laser enucleation in prostate sizes 80-180mL. The study treated 186 men between December 2020 and ...
Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.
As of 10:00:24 AM GMT+2. Market Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback